openPR Logo
Press release

Tumor Ablation Market Size to Reach USD 1.9 Billion by 2025 | Industry Players - EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp. and others.

04-11-2019 01:59 PM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Tumor Ablation Market

Tumor Ablation Market

The global tumor ablation market is anticipated to reach USD 1.9 billion by 2025 according to a new study published by Polaris Market Research. Ablation is treatment for the destruction of liver tumors without removing them. These technique is used in patients with few small tumors and when surgery is not a worthy option due to reduced liver function or poor health condition. These treatments are sometimes used in patients waiting for a liver transplant.

Request for sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/request-for-sample

Generally, tumor ablation is a minimally invasive surgical method to treat solid cancers. Special probes are used to freeze or burn cancers without the surgery. Ultrasound (US), Computed Tomography (CT), or Magnetic Resonance Imaging (MRI) are used to guide and position the needle probe into the tumor. The most common cancers treated by this method are lung cancer, liver cancer and kidney (renal) cancer. Other cancers can also be treated if the tumor cell are accessible to reach and of appropriate size

The global tumor ablation market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of tumor ablation for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional or traditional surgical procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the continual developments in ablation expertise, leading to the increased development of new and pioneering products that are the efficient, safe, and minimally invasive are also advancing towards significant growth of the global tumor ablation market.

With the increasing geriatric population, the demand for minimally invasive surgeries (MIS) is increasing globally. Through minimally intrusive surgeries, the patients result in faster recovery in comparison to conventional invasive procedures. Therefore, the demand for minimally invasive procedures such as radiofrequency ablation and cryoablation is increasing and thereby augmenting the global market growth.

Browse summary of this report with TOC @ https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market

The global tumor ablation market is segmented on the basis of type of technology, mode of treatment, and application. On the basis of type of technology, the global tumor ablation market is segmented into Radiofrequency (RF) ablation, Microwave ablation, Cryoablation, and others. The radiofrequency ablation is estimated to dominate the global tumor ablation market owing to its design of treating target tissues without causing damage to the surrounding healthy cells. However, microwave ablation technology is expected to grow at the rapid test rate in the upcoming years, due to increasing adoption of microwave tumor ablation among healthcare specialists.

On the basis of the type of technology, the global tumor ablation market is further categorized into surgical ablation, laparoscopic ablation, and percutaneous ablation. Moreover, on the basis of application the market is segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, and others. Lung cancer is anticipated to grow with the fastest rate in the forecast period due to growing prevalence of lung cancer cases and increasing private as well as government investment to develop new lung cancer ablation products.

Inquire before-buying @ https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/inquire-before-buying

Some of the key players operating in global tumor ablation market are EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp., BTG International Ltd., Integra LifeSciences Holdings Corp., and Medtronic plc. among others.

Key Segments:

Tumor ablation Market Size and Forecast by type of technology

• Key findings
• Radiofrequency (RF) ablation
• Microwave ablation
• Cryoablation
• Others

Tumor ablation Market Size and Forecast by Mode of treatment

• Key findings
• Surgical ablation
• Laparoscopic ablation
• Percutaneous ablation

Tumor ablation Market Size and Forecast by Application

• Key findings
• Liver cancer
• Lung cancer
• Kidney cancer
• Bone metastasis
• Others

Check for discount @ https://www.polarismarketresearch.com/industry-analysis/global-tumor-ablation-market/request-for-discount-pricing

About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers.

Contact us

Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumor Ablation Market Size to Reach USD 1.9 Billion by 2025 | Industry Players - EDAP TMS S.A., St. Jude Medical Inc., BVM Medical Ltd., SonaCare Medical LLC, AngioDynamics Inc., Boston Scientific Corp. and others. here

News-ID: 1699527 • Views:

More Releases from Polaris Market Research & Consulting

Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR of 7.70% | Polaris Market Research
Cooling Fabrics Market Is Expected to Reach US$ 4.66 Billion by 2032, at a CAGR …
𝑻𝒉𝒆 𝒈𝒍𝒐𝒃𝒂𝒍 𝑪𝒐𝒐𝒍𝒊𝒏𝒈 𝑭𝒂𝒃𝒓𝒊𝒄𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝒘𝒂𝒔 𝒆𝒔𝒕𝒆𝒆𝒎𝒆𝒅 𝒂𝒕 𝑼𝑺𝑫 2.42 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2023. 𝑳𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅, 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒂𝒏𝒕𝒊𝒄𝒊𝒑𝒂𝒕𝒆𝒅 𝒕𝒐 𝒈𝒓𝒐𝒘 𝒕𝒐 𝑼𝑺𝑫 4.66 𝒃𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2032, 𝒆𝒙𝒉𝒊𝒃𝒊𝒕𝒊𝒏𝒈 𝒂 𝒄𝒐𝒎𝒑𝒐𝒖𝒏𝒅 𝒂𝒏𝒏𝒖𝒂𝒍 𝒈𝒓𝒐𝒘𝒕𝒉 𝒓𝒂𝒕𝒆 (𝑪𝑨𝑮𝑹) 𝒐𝒇 7.70% 𝒐𝒗𝒆𝒓 𝒕𝒉𝒆 𝒇𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒑𝒆𝒓𝒊𝒐𝒅 𝒇𝒓𝒐𝒎 2024 𝒕𝒐 2032. 𝑻𝒉𝒆 𝒎𝒂𝒊𝒏 𝒇𝒂𝒄𝒕𝒐𝒓𝒔 𝒅𝒓𝒊𝒗𝒊𝒏𝒈 𝒕𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒈𝒓𝒐𝒘𝒕𝒉 𝒂𝒓𝒆 𝒓𝒊𝒔𝒊𝒏𝒈 𝒅𝒊𝒔𝒑𝒐𝒔𝒂𝒃𝒍𝒆 𝒊𝒏𝒄𝒐𝒎𝒆 𝒂𝒏𝒅 𝒑𝒆𝒓 𝒄𝒂𝒑𝒊𝒕𝒂 𝒔𝒑𝒆𝒏𝒅𝒊𝒏𝒈, 𝒂𝒔 𝒘𝒆𝒍𝒍 𝒂𝒔 𝒂 𝒓𝒊𝒔𝒆 𝒊𝒏 𝒕𝒉𝒆 𝒅𝒆𝒎𝒂𝒏𝒅 𝒇𝒐𝒓 𝒔𝒑𝒐𝒓𝒕𝒔 𝒂𝒏𝒅
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2032 |according to a new study by Polaris Market Research
Connected Medical Devices Market is projected to grow to US$ 190.63 Billion by 2 …
The global Connected Medical Devices Market was valued at USD 49.57 billion in 2022. Looking forward, the market is projected to grow to USD 190.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.4% over the forecast period from 2023 to 2032. The rising aging population and the expansion of telehealth services are the primary factors propelling the market forward. Besides, the growing prevalence of chronic diseases
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by Polaris Market Research
Surgical Blade Market is expected to reach US$ 228.57 Million by 2032 | Data by …
According to a new market research report published by Polaris Market Research, the global Surgical Blade Market is expected to grow at a CAGR of 5.0% from 2023 to 2032. Its examination of technological progressions and developments in the industry and their influence on market attendance is anticipated to drive market expansion. The global market was valued at USD 140.59 million in 2022 to USD 228.57 million by 2032, disclosing
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion By 2032
Fructooligosaccharides Market to Grow at CAGR of 8.50% Reaching USD 5.71 Billion …
𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 Continuing research into the health benefits of FOS and inventive commodity advancement has the possibility of capitulating new FOS-dependent commodities with improved functionality, which is pushing the market growth. Our thorough analysis of the Fructooligosaccharides Market covers the industry size, share, recent developments, and top trends. Besides, we have in-depth examined all the major regions and segments. 𝐓𝐡𝐞 𝐅𝐫𝐮𝐜𝐭𝐨𝐨𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 • Market Size: The global market for fructooligosaccharides was valued

All 5 Releases


More Releases for Tumor

Tumor Ablation Market Industry Analysis - Tumor Ablation Market Size Driven by R …
The most recent study offered by Acumen Research and Consulting focuses Tumor Ablation Market size, share, growth rate, and market trends, as well as the parameters and factors influencing it in both the long term and short term. The report investigates the Tumor Ablation Market trends in order to assess its current and future potential. Our Tumor Ablation Market analysis also provides market participants and new entrants with a comprehensive
Brain Tumor Treatment Market
Brain Tumor Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025 The global Brain Tumor Diagnosis and Treatments market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis and Treatments
Rising Prevalence of brain Tumor Couple with Geriatric Populations supporting gr …
Albany, NY, 26th February : Recent research and the current scenario as well as future market potential of "Brain Tumor Therapeutics: Global Markets to 2023" globally. ResearchMOZ.us has published a fresh report to its vast repository titled “Global Brain Tumor Therapeutics Market - Segmented by Type of Cancer and Therapeutics - Growth, Trends and Forecasts 2018-2026” to its offerings. The report provides comprehensive analysis of the global tumor therapeutics market in the
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed